Dr. Chris VanDeusen, Chief Scientific Officer, will present “TCR-Nck Modulators: Pioneering Oral Modulation of T Cell Receptor Activation Holding the Promise of Treating Dermatologic Diseases,” ...
The peptide is primarily studied for its potential to influence pigmentation Melanotan-2 (MT-2), a synthetic peptide derived ...